Latest Antidepressant Stories
-- Sales Force Increased to Approximately 600 Sales Specialists -- SAN DIEGO, July 10, 2014 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) today reported that Eisai Inc.
Three-part study explores challenges and opportunities facing the depression-treatment landscape a year after 25th anniversary of the U.S.
Cognitive Deficit and Depression Symptoms Improve Significantly, Trial Data Shows GERMANTOWN, Md., June 25, 2014 /PRNewswire/ -- Neuralstem, Inc.
Pharmacogenomic test now available to help guide clinicians' medication decisions for veterans being treated for mental health conditions MASON, Ohio, June 24, 2014 /PRNewswire/ --
Data Highlight Physician and Payer Receptivity to Emerging Agents for Treatment-Resistant Depression, According to Findings from Decision Resources Group BURLINGTON, Mass., June 23, 2014 /PRNewswire/
In an attempt to raise awareness about a potential increased risk of suicide tied to antidepressant use, health officials may have made inadvertently made the problem worse.
The New Website Offers Visitors Information About SSRIs and Autism, Autism Diagnoses, and How to Receive Compensation for Being Prescribed Autism-Inducing Medications HOUSTON, June
There is new hope for people suffering from depression.
Takeda and Lundbeck Announce Results at American Society of Clinical Psychopharmacology Annual Meeting HOLLYWOOD, Fla., June 17, 2014 /PRNewswire/ -- Takeda Pharmaceuticals Company Limited
Lack of Disease-Modifying Therapies is Expected to Remain a Critical Unmet Need and Provides Ample Opportunity for Developers, According to Findings from Decision Resources Group BURLINGTON,
- a slit in a tire to drain away surface water and improve traction.